Enabling rational, accelerated 4D structural drug design using experimental rather than theoretical data

C4X Discovery operates rational, accelerated drug design using experimental data to identify the important molecular shapes and from those design and develop safer and better drugs.

Our Conformetrix patented technology platform allows the dynamic 3D-shapes of free drug molecules to be precisely measured from experimental data, giving medicinal chemists new and unprecedented insights into the behaviour and physical properties of drug molecules.

The measurement, analysis and use of dynamic 3D-shapes is at the heart of the C4X drug discovery engine. The focus and clarity that these provide allow us to make rapid progress in developing new and better drugs at a fraction of the cost compared to best industry practice.

1. Conformetrix

The importance of drug 3D-shapes

At C4X Discovery we have addressed the clear need for precise measurement of a small molecule's 3D-shapes by using our proprietary technology platform with measured experimental data.

Read More

2. Conformational analysis

Measuring drug 3D-shapes

The method was developed by C4X Discovery founders Charles Blundell and Andrew Almond to address the inadequacy of existing experimental and computational chemistry methods to determine this information.

Read More

3. Conformational design

Using drug 3D-shapes

‘Conformational design’ aims to make rational, precision changes to molecules so that they are the right shape for binding with the target for as much time as possible.

Read More